OneMedNet Corp
Close on Oct 19, 2026
- Market cap
- $268.05M
- P/E (TTM)
- –
- Dividend yield
- –
About OneMedNet
Services-Commercial Physical & Biological Research, SIC 8731
OneMedNet Corporation operates within healthcare technology, specializing in clinical image exchange and regulatory-grade real-world data management. The company generates revenue primarily through subscription services and specialized data delivery offerings. Through its platform and solutions, OneMedNet connects healthcare providers, life science organizations, and academic medical researchers to securely access, transmit, and analyze clinical data. Its technological framework facilitates data interoperability across disparate systems while maintaining rigorous compliance with medical data privacy and regulatory frameworks.
The company conducts commercial activities across North America, Europe, the Middle East, and the Asia-Pacific region. Its operations encompass customer contracts and partner networks spanning multiple regional markets. OneMedNet Corporation maintains its principal executive offices in Eden Prairie, Minnesota.
Summary of the business section of OneMedNet's latest annual report, written by StockData.
Company profile
Company
- Legal name
- OneMedNet Corp
- Headquarters
- Surrey, X0
- Address
- Trident Court, 1 Oakcroft Road, Chessington KT9 1BD
- Phone
- 011-44-208-090-2009
- Employees
- 23, Dec 31, 2025
- Industry
- Services-Commercial Physical & Biological Research
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- WithumSmith+Brown, PC, East Brunswick, New Jersey
Stock & identifiers
- Ticker
- ONMD
- Other tickers
- ONMDW
- Exchange
- Nasdaq
- IPO date
- May 10, 2021
- Shares outstanding
- 59M, Aug 11, 2026
- Public float
- $13.80M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-10 reverse, Sep 29, 2026
- SEC CIK
- 1849380
- CUSIP
- 68270C103
- ISIN
- US68270C1036
- EIN
- 86-2076743
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Jeffrey Yu | Chief Medical Officer, Director | 10,235,237 |
| Aaron Green | Chief Executive Officer, Director | 1,896,375 |
| Thomas Kosasa | Director | 18,538,150 |
| Robert Lawrence Golden | Director | 547,905 |
| Jair Clarke | Director | 138,485 |
| Sherry Coonse McCraw | Director | 56,342 |
| Eric Casaburi | Director | 110,475 |
| Kenneth Alleyne | Director | 38,219 |
| Andrew B. Zeinfeld | Director | 381,525 |
Employees
Headcount reported in annual reports
“workforce is comprised of approximately 23 employees (as of December 31, 2025), including approximately 1 part-time employee (references”
Corporate history
Events identified from SEC filings